Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient Lymphocytes

The Wiskott-Aldrich syndrome protein (WASp) has been implicated in modulation of lymphocyte activation and cytoskeletal reorganization. To address the mechanisms whereby WASp subserves such functions, we have examined WASp roles in lymphocyte development and activation using mice carrying a WAS null allele (WAS − / −). Enumeration of hemopoietic cells in these animals revealed total numbers of thymocytes, peripheral B and T lymphocytes, and platelets to be significantly diminished relative to wild-type mice. In the thymus, this abnormality was associated with impaired progression from the CD44−CD25+ to the CD44−CD25− stage of differentiation. WASp-deficient thymocytes and T cells also exhibited impaired proliferation and interleukin (IL)-2 production in response to T cell antigen receptor (TCR) stimulation, but proliferated normally in response to phorbol ester/ionomycin. This defect in TCR signaling was associated with a reduction in TCR-evoked upregulation of the early activation marker CD69 and in TCR-triggered apoptosis. While induction of TCR-ζ, ZAP70, and total protein tyrosine phosphorylation as well as mitogen-activated protein kinase (MAPK) and stress-activated protein/c-Jun NH2-terminal kinase (SAPK/JNK) activation appeared normal in TCR-stimulated WAS − / − cells, TCR-evoked increases in intracellular calcium concentration were decreased in WASp-deficient relative to wild-type cells. WAS − / − lymphocytes also manifested a marked reduction in actin polymerization and both antigen receptor capping and endocytosis after TCR stimulation, whereas WAS − / − neutrophils exhibited reduced phagocytic activity. Together, these results provide evidence of roles for WASp in driving lymphocyte development, as well as in the translation of antigen receptor stimulation to proliferative or apoptotic responses, cytokine production, and cytoskeletal rearrangement. The data also reveal a role for WASp in modulating endocytosis and phagocytosis and, accordingly, suggest that the immune deficit conferred by WASp deficiency reflects the disruption of a broad range of cellular behaviors.

[1]  Laura M. Machesky,et al.  Scar1 and the related Wiskott–Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex , 1998, Current Biology.

[2]  M. Davis,et al.  A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.

[3]  Shiro Suetsugu,et al.  WAVE, a novel WASP‐family protein involved in actin reorganization induced by Rac , 1998, The EMBO journal.

[4]  A. Weiss,et al.  A Nck‐Pak1 signaling module is required for T‐cell receptor‐mediated activation of NFAT, but not of JNK , 1998, The EMBO journal.

[5]  C. Saxe,et al.  SCAR, a WASP-related Protein, Isolated as a Suppressor of Receptor Defects in Late Dictyostelium Development , 1998, The Journal of cell biology.

[6]  Patricia L. Widder,et al.  A Novel Adaptor Protein Orchestrates Receptor Patterning and Cytoskeletal Polarity in T-Cell Contacts , 1998, Cell.

[7]  Brian J. Stevenson,et al.  The WASp homologue Las17p functions with the WIP homologue End5p/verprolin and is essential for endocytosis in yeast , 1998, Current Biology.

[8]  R. Badolato,et al.  Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. , 1998, Journal of immunology.

[9]  Philip R. Cohen,et al.  Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. , 1998, Immunity.

[10]  Dunn,et al.  Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome , 1998, British journal of haematology.

[11]  M. Davis,et al.  Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Tedford,et al.  Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor , 1998, Current Biology.

[13]  T. Takenawa,et al.  Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization. , 1998, Biochemical and biophysical research communications.

[14]  Yoshimi Takai,et al.  Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.

[15]  A. Nagy,et al.  Embryonic stem cells, creating transgenic animals. , 1998, Methods in cell biology.

[16]  M. Gallego,et al.  Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation , 1997 .

[17]  R. Zamoyska,et al.  A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. , 1997, Immunity.

[18]  O. Majdic,et al.  Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. , 1997, Blood.

[19]  K. Siminovitch,et al.  Flow cytometric analysis of platelets from childrenwith the Wiskott‐Aldrich syndrome reveals defects in platelet development, activation and structure , 1997, British journal of haematology.

[20]  M. Gallego,et al.  Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. , 1997, Blood.

[21]  C. Der,et al.  Lck regulates Vav activation of members of the Rho family of GTPases , 1997, Molecular and cellular biology.

[22]  Rong Li,et al.  Bee1, a Yeast Protein with Homology to Wiscott-Aldrich Syndrome Protein, Is Critical for the Assembly of Cortical Actin Cytoskeleton , 1997, The Journal of cell biology.

[23]  H. Ochs,et al.  Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  K. Schuebel,et al.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.

[25]  R C Lovering,et al.  Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. , 1996, Journal of immunology.

[26]  P. Finan,et al.  Identification of Regions of the Wiskott-Aldrich Syndrome Protein Responsible for Association with Selected Src Homology 3 Domains* , 1996, The Journal of Biological Chemistry.

[27]  R. Rickles,et al.  Identification of Itk/Tsk Src Homology 3 Domain Ligands* , 1996, The Journal of Biological Chemistry.

[28]  K. Miura,et al.  N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.

[29]  I. Gout,et al.  Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases , 1996, Current Biology.

[30]  L. Notarangelo,et al.  Studies of the expression of the Wiskott-Aldrich syndrome protein. , 1996, The Journal of clinical investigation.

[31]  D. Alexander,et al.  CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation , 1996, The Journal of experimental medicine.

[32]  U. Francke,et al.  Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.

[33]  C. Clendenin,et al.  Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB , 1996, Nature.

[34]  Uno Lindberg,et al.  Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndrome , 1996, Current Biology.

[35]  A. Marcilla,et al.  Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains , 1995, Molecular and cellular biology.

[36]  V. Maino,et al.  Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. , 1995, Blood.

[37]  J. Chant,et al.  Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Nobes,et al.  Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.

[39]  M. Barbacid,et al.  Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.

[40]  F. Alt,et al.  Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.

[41]  K. Rajewsky,et al.  Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.

[42]  A. Lanzavecchia,et al.  Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton , 1995, The Journal of experimental medicine.

[43]  K. Sullivan,et al.  A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.

[44]  C. Saint‐Ruf,et al.  Analysis and expression of a cloned pre-T cell receptor gene. , 1994, Science.

[45]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.

[46]  K. Siminovitch,et al.  Molecular characterization of the X-linked immunodeficiency diseases , 1994 .

[47]  C. Terhorst,et al.  T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. , 1993, Journal of immunology.

[48]  V. Stewart,et al.  RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Zlotnik,et al.  A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. , 1993, Journal of immunology.

[50]  R. Perlmutter,et al.  A dominant‐negative transgene defines a role for p56lck in thymopoiesis. , 1993, The EMBO journal.

[51]  W. Swat,et al.  CD 69 expression during selection and maturation of CD4+8+ thymocytes , 1993, European journal of immunology.

[52]  G. Mills,et al.  Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. , 1992, The Journal of clinical investigation.

[53]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[54]  K. Weinberg,et al.  Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome , 1991, The Journal of experimental medicine.

[55]  J. Dennis,et al.  Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. , 1991, The Journal of biological chemistry.

[56]  J. Dennis,et al.  Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. , 1989, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[57]  T. Morio,et al.  The increase of non-MHC-restricted cytotoxic cells (γδ-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome , 1989 .

[58]  R. Testi,et al.  Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. , 1989, Journal of immunology.

[59]  K. Siminovitch,et al.  X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. , 1989, Genomics.

[60]  R. Parkman,et al.  Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. , 1986, Blood.

[61]  Y. Misumi,et al.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. , 1986, The Journal of biological chemistry.

[62]  P. Rabinovitch,et al.  Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. , 1986, Journal of immunology.

[63]  M. Condorelli,et al.  The Wiskott‐Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes , 1986, British journal of haematology.

[64]  B. Golding,et al.  Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP-Brucella abortus behaves as a T-independent type 1 antigen in humans. , 1984, Journal of immunology.

[65]  E. Nishida,et al.  Cofilin, a protein in porcine brain that binds to actin filaments and inhibits their interactions with myosin and tropomyosin. , 1984, Biochemistry.

[66]  E. Unanue,et al.  Ligand-induced association of surface immunoglobulin with the detergent-insoluble cytoskeletal matrix of the B lymphocyte. , 1982, Journal of immunology.

[67]  L. Harker,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets , 1980 .

[68]  H. Ochs,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. , 1980, Blood.

[69]  J. Harley,et al.  Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection. , 1980, Blood.

[70]  D. Stites,et al.  The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members. , 1975, Cellular immunology.

[71]  T. Hovig,et al.  Wiskott—Aldrich Syndrome: Qualitative Platelet Defects and Short Platelet Survival , 1969, British journal of haematology.

[72]  M. Cooper,et al.  Wiskott-Aldrich syndrome: An immunologic deficiency disease involving the afferent limb of immunity , 1968 .

[73]  Aldrich Ra,et al.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954 .

[74]  D. C. Campbell,et al.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954, Pediatrics.